# Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (Text with EEA relevance), Division 2.2.2: Exposure to risk of acquiring a transfusion-transmissible infection

Extent: E+W+S+N.I.

Endoscopic examination using flexible instruments,
mucosal splash with blood or needlestick injury,
transfusion of blood components,
tissue or cell transplant of human origin,
major surgery,
tattoo or body piercing,
acupuncture unless performed by a qualified practitioner and with sterile single-use needles,
persons at risk due to close household contact with persons with hepatitis B.
Defer for 6 months, or for 4 months provided a NAT test for hepatitis C is negative
Persons whose behaviour or activity places them at risk of acquiring infectious diseases that may be transmitted by blood.
Defer after cessation of risk behaviour for a period determined by the disease in question, and by the availability of appropriate tests

---
Source: https://www.legislation.gov.uk/eudr/2004/33/annex/III/division/2/division/2.2/division/2.2.2 (the official version)
Page: https://openlegislation.uk/eu-directive-2004-33/annex-III/division-2/division-2.2/division-2.2.2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.